文献速递免疫规划卫生政策与健康促进

坦桑尼亚国家引入人乳头瘤病毒(HPV)疫苗:项目决策与实施

National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
PubMed 文献 · Vaccine · 2021-05-04

坦桑尼亚于2018年4月在全国范围为青春期女孩引入2剂HPV疫苗以预防宫颈癌,此前在乞力马扎罗地区成功试点2年。研究通过关键知情人访谈和文件审查,发现疫苗纳入常规免疫策略,2019年底首剂行政覆盖率为78%,第二剂为49%,未报告至国家层面的不良事件。

要点

  • 坦桑尼亚采用常规免疫策略为14岁女孩接种HPV疫苗,首剂覆盖率78%,第二剂49%。
  • 决策过程涉及国家免疫技术咨询组和跨部门协调委员会。
  • 全国培训超6000名卫生工作者和22000名学校人员,未报告至国家层面的不良事件。

核心结论

  • 坦桑尼亚成功采用常规免疫策略在全国范围为14岁女孩引入HPV疫苗,但第二剂覆盖率有待提高。

主要发现

  • 共访谈来自卫生部、世界卫生组织及其他合作伙伴的10名关键知情人,并审查了HPV疫苗规划文件和行政覆盖数据。
  • 2019年底HPV疫苗首剂行政覆盖率为78%,第二剂覆盖率为49%。
  • 未报告至国家层面的HPV疫苗接种后不良事件。

关键数值与推荐

  • 全国目标人群为14岁女孩单一年龄队列,接种2剂HPV疫苗。
  • 2019年底首剂行政覆盖率78%,第二剂49%。
  • 全国培训超过6000名卫生工作者和22000名学校人员。

临床怎么用

  • 将HPV疫苗纳入常规免疫服务,通过卫生设施、社区外展点、社区移动点(距卫生设施>10公里)及中小学提供接种。
  • 开展培训和微观规划工作坊,覆盖国家、地区、委员会和卫生设施各级卫生工作者及学校人员。
  • 持续监测接种覆盖率以确保符合条件女孩完成2剂接种,可考虑定期强化接种和针对性社会动员。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cervical cancer is the leading cause of cancer among women in Tanzania, with approximately 10,000 new cases and 7,000 deaths annually. In April 2018, the Government of Tanzania introduced 2 doses of human papillomavirus (HPV) vaccine nationally to adolescent girls to prevent cervical cancer, following a successful 2-year pilot introduction of the vaccine in the Kilimanjaro Region. METHODS: We interviewed key informants at the national level in Tanzania from February to November 2019, using a semi-structured tool to better understand national decision-making and program implementation. We conducted a comprehensive desk review of HPV vaccine introduction materials and reviewed administrative coverage data. RESULTS: Ten key informants were interviewed from the Ministry of Health, Community Development, Gender, Elderly, and Children, the World Health Organization, and other partners, and HPV vaccine planning documents and administrative coverage data were reviewed during the desk review. Tanzania introduced HPV vaccine to a single-age cohort of 14-year-old girls, with the decision-making process involving the Tanzania Immunization Technical Advisory Group and the national Interagency Coordination Committee. HPV vaccine was integrated into the routine immunization delivery strategy, available at health facilities and through outreach services at community sites, community mobile sites (>10 km from the health facility), and primary and secondary schools. Pre-introduction activities included trainings and microplanning workshops for health workers and school personnel at the national, regional, council, and health facility levels. Over 6,000 health workers and 22,000 school personnel were trained nationwide. Stakeholder and primary health care committee meetings were also conducted at the national level and in each of the regions as part of the advocacy and communication strategy. Administrative coverage of the first dose of HPV vaccine at the end of 2019 was 78%, and second dose coverage was 49%. No adverse events following HPV vaccination were reported to the national level. DISCUSSION: Tanzania successfully introduced HPV vaccine nationally targeting 14-year-old girls, using routine delivery strategies. Continued monitoring of vaccination coverage will be important to ensure full 2-dose vaccination of eligible girls. Tanzania can consider periodic intensified vaccination and targeted social mobilization efforts, as needed.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Mphuru A, Li AJ, Kyesi F, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation. Vaccine. 2021. PMID: 33962839. doi:10.1016/j.vaccine.2021.04.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。